Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity
Mosselhy DA, He W, Hynönen U, et al. Int J Nanomedicine. 2018;13:7939–7957. On page 7945, Figure 1 parts were labeled incorrectly. Read the original article
Guardado en:
Autores principales: | Mosselhy DA, He W, Hynönen U, Meng Y, Mohammadi P, Palva A, Feng Q, Hannula SP, Nordström K, Linder MB |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1f94534439884452b18d98ac89bddb3a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity
por: Mosselhy DA, et al.
Publicado: (2018) -
Effects of silica–gentamicin nanohybrids on osteogenic differentiation of human osteoblast-like SaOS-2 cells
por: He W, et al.
Publicado: (2018) -
Combating Intracellular Pathogens with Nanohybrid-Facilitated Antibiotic Delivery
por: Bose RJC, et al.
Publicado: (2020) -
Glycogen–gold nanohybrid escalates the potency of silymarin
por: Kandimalla R, et al.
Publicado: (2017) -
Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcumin
por: Li C, et al.
Publicado: (2012)